|
1
|
Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
|
Arch Gen Psychiatry
|
2010
|
3.82
|
|
2
|
Psychotic-like experiences in nonpsychotic help-seekers: associations with distress, depression, and disability.
|
Schizophr Bull
|
2005
|
1.38
|
|
3
|
The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.
|
Schizophr Bull
|
2010
|
1.32
|
|
4
|
Recognition of depression and psychosis by young Australians and their beliefs about treatment.
|
Med J Aust
|
2005
|
1.23
|
|
5
|
Family outcomes from a randomized control trial of relapse prevention therapy in first-episode psychosis.
|
J Clin Psychiatry
|
2009
|
1.13
|
|
6
|
The reliability and validity of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in first-episode psychosis.
|
Addict Behav
|
2009
|
1.01
|
|
7
|
Association between psychotic experiences and depression in a clinical sample over 6 months.
|
Schizophr Res
|
2007
|
0.98
|
|
8
|
The predictive validity of bipolar at-risk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study.
|
Bipolar Disord
|
2014
|
0.95
|
|
9
|
A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults.
|
J Affect Disord
|
2010
|
0.93
|
|
10
|
A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients.
|
J Clin Psychiatry
|
2009
|
0.93
|
|
11
|
The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.
|
J Affect Disord
|
2011
|
0.91
|
|
12
|
Distinguishing between anxiety and depression using the Mood and Anxiety Symptoms Questionnaire (MASQ).
|
Br J Clin Psychol
|
2007
|
0.89
|
|
13
|
A randomized controlled trial of bibliotherapy for carers of young people with first-episode psychosis.
|
Schizophr Bull
|
2012
|
0.86
|
|
14
|
A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis.
|
Schizophr Res
|
2010
|
0.85
|
|
15
|
The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial.
|
J Clin Psychiatry
|
2014
|
0.84
|
|
16
|
A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients: outcome at 30-month follow-up.
|
Schizophr Bull
|
2011
|
0.84
|
|
17
|
Outcomes of an integrated cognitive behaviour therapy (CBT) treatment program for co-occurring depression and substance misuse in young people.
|
J Affect Disord
|
2009
|
0.83
|
|
18
|
Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial.
|
BMC Med
|
2012
|
0.83
|
|
19
|
The relationship between personality disorders and mental health, substance use severity and quality of life among injecting drug users.
|
Med J Aust
|
2011
|
0.79
|
|
20
|
Treating co-occurring first-episode psychosis and borderline personality: a pilot randomized controlled trial.
|
Early Interv Psychiatry
|
2012
|
0.78
|
|
21
|
A factor analytic investigation of the Tripartite model of affect in a clinical sample of young Australians.
|
BMC Psychiatry
|
2008
|
0.78
|
|
22
|
Cannabis use disorder and age at onset of psychosis--a study in first-episode patients.
|
Schizophr Res
|
2011
|
0.78
|
|
23
|
Does the addition of integrated cognitive behaviour therapy and motivational interviewing improve the outcomes of standard care for young people with comorbid depression and substance misuse?
|
Med J Aust
|
2011
|
0.78
|
|
24
|
The effects of inhalant misuse on attentional networks.
|
Dev Neuropsychol
|
2013
|
0.77
|
|
25
|
Differentiating schizoaffective and bipolar I disorder in first-episode psychotic mania.
|
Schizophr Res
|
2012
|
0.75
|
|
26
|
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.
|
Trials
|
2014
|
0.75
|
|
27
|
Predictors of Substance Use in Youth With Borderline Personality Disorder.
|
Personal Disord
|
2017
|
0.75
|